NeuroLogica Receives Canadian Medical Device License for the CereTom(TM) CT Scanner

    Approval Clears the Way for NeuroLogica to Install First Ever Portable CT
Scanner in Medical Facilities Throughout Canada

    DANVERS, MASS., March 5 /CNW/ - NeuroLogica Corporation, a
neuroscience-based medical imaging company, today announced that its
CereTom(TM) has received the Canadian Medical License. This approval will
allow entry of the CereTom(TM), the first portable and cordless CT scanner,
into hospitals, walk-in clinics and private practice medical offices
throughout Canada.

    Canada's medical device license regulations call for manufacturers to
provide substantial scientific evidence of a product's safety, efficacy and
quality based on objective evidence, which the CereTom has met. In addition, a
medical device must bear a label that contains specific information as
described in the regulations.

    "This is a major accomplishment for our company, and it will allow us to
further our mission, of bringing greater access globally to quality, mobile
neuro-imaging," said Eric Bailey, President and Co-founder of NeuroLogica
Corporation. "Leading medical centers in the United States and Europe are
already using the CereTom in the ER, OR and ICU departments. Additionally, we
are opening up distribution networks in Asia and Latin America. Now, hospitals
in Canada will have access to more rapid scans for critical patients as
NeuroLogica's portable CT scanner will ultimately improve patient care.

    The CereTom(TM) is now installed at 30 hospitals and medical centers
across the US and Europe including The Massachusetts General Hospital and UCLA
Medical Center. NeuroLogica will next apply for the appropriate certification
required for global distribution including Japan, China, Hong Kong, Korea, and

    About NeuroLogica:

    Based in Danvers, Mass., NeuroLogica Corporation, a neuro-science based
imaging company, develops, manufactures and markets advanced medical imaging
equipment. The company's mission is to bring access to high quality
neuro-imaging to all people regardless of where they live. Combining superior
imaging quality and easy access enables physicians to make more informed
treatment decisions that save and improve patient lives, specifically in
neuro-related conditions.

For further information:

For further information: Racepoint Group Tom Bain/Andrea Krull,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890